Gender differences in hostility of opioid-dependent outpatients: Role in early treatment termination

Drug and Alcohol Dependence

Volumn 58, Issue 1-2, 2000, Pages 27-33

  Petry, Nancy M ^a   Bickel, Warren K ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

Buprenorphine; Early termination; Gender differences; Heroin; Hostility; Opioid dependence; Retention; Substance abuse treatment

Indexed keywords

BUPRENORPHINE; NALTREXONE;

ADULT; ARTICLE; CONTROLLED STUDY; DETOXIFICATION; DISEASE SEVERITY; DRUG DEPENDENCE TREATMENT; FEMALE; GENDER; HOSTILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; OPIATE ADDICTION; OUTPATIENT; PATIENT COMPLIANCE; PERSONALITY; PREDICTION; PRIORITY JOURNAL;

ADULT; BUPRENORPHINE; CHI-SQUARE DISTRIBUTION; FEMALE; HOSTILITY; HUMANS; LOGISTIC MODELS; MALE; NALTREXONE; NARCOTIC ANTAGONISTS; OPIOID-RELATED DISORDERS; PATIENT COMPLIANCE; PATIENT DROPOUTS; PERSONALITY INVENTORY; PSYCHOMETRICS; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 0033990668     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(99)00058-7     Document Type: Article

References (63)

1. Alterman A.I., Cacciola J.S. The antisocial personality disorder diagnosis in substance abusers: Problems and issues. J. Nerv. Ment. Dis. 179:1991;401-409.
2. Altman H., Evenson R., Cho D.W. Prediction length of stay by patients hospitalized for alcoholism and drug dependence. J. Stud. Alcohol. 39:1978;197-201.
3. Anglin B., Hser Y., Booth M.W. Sex differences in addict careers: 4. Treatment. Am. J. Drug Alcohol Abuse. 13:1987;253-280.
4. Baekland F., Lundwall L. Dropping out of treatment: A critical review. Psychol. Bull. 82(5):1975;738-783.
5. Ball S.A. The validity of an alternative five factor measure of personality in cocaine abusers. Psychol. Assess. 7:1995;148-154.
6. Ball J.C., Ross A. The effectiveness of methadone maintenance treatment. 1991;Springer-Verlag, New York.
7. Ball S.A., Schottenfeld R. A five-factor model of personality and addition, psychiatric and AIDS risk severity in pregnant and postpartum cocaine misusers. Subst. Use Misuse. 32:1997;25-41.
8. Ball J.C., Rosen L., Flueck J., Nurco D.N. The criminality of heroin addicts when addicted and when off opiates. Inciardi J.A. The drug-crime connection. 5:1981;39-65 Sage Publications, Beverly Hills.
9. Biaggio M.D., Supplee K., Curtis N. Reliability and validity of four anger scales. J. Pers. Assess. 45:1981;639-647.
10. Bickel W.K., Amass L. Buprenorphine treatment of opioid dependence: A review. Exp. Clin. Psychopharmacol. 3:1995;477-489.
11. Bickel W.K., Stitzer M.L., Bigelow G.E., Liebson I.A., Jasinski D.R., Johnson R.E. A clinical trial of buprenorphine: Comparison with methadone in the detoxification of heroin addicts. Clin. Pharm. Ther. 43:1988;72-78.
12. Bickel W.K., Stitzer M.L., Bigelow G.E., Liebson I.A., Jasinski D.R., Johnson R.E. Buprenorphine: Dose-related blockade of opioid challenge effects in opioid dependent humans. J. Pharm. Exp. Ther. 247:1988;47-53.
13. Bickel W.K., Amass L., Higgins S.T., Badger G.J., Esch R.A. Effects of behavioral treatment during opioid detoxification with buprenorphine. J. Consult. Clin. Psychol. 65:1997;803-810.
14. Brown L.S., Alterman A.I., Rutherford M.J., Cacciola J.S. Addiction Severity Index scores of four racial/ethnic and gender groups of methadone maintenance patients. J. Subst. Abuse. 5(Suppl. 3):1993;269-279.
15. Buss A.H., Durkee A. An inventory for assessing different kinds of hostility. J. Consult. Psychol. 21(Suppl. 4):1957;343-349.
16. Carroll K.M., Ball S., Rounsaville B.J. A comparison of alternate systems for diagnosing antisocial personality disorder in cocaine abusers. J. Nerv. Mental Dis. 181(Suppl. 7):1993;436-443.
17. el-Guebaly N. Substance use disorders and mental illness: The relevance of comorbidity. Can. J. Psychiatry. 40(Suppl. 1):1995;2-3.
18. Fals-Steward W., Lucente S. Effect of neurocognitive status and personality functioning on length of stay in residential substance abuse treatment: An integrative study. Psychol. Addict. Behav. 8(Suppl. 3):1994;179-190.
19. Fals-Steward W., Schafer J. The relationship between length of stay in drug-free therapeutic communities and neurocognitive functioning. J. Clin. Psychol. 48(Suppl. 4):1992;539-543.
20. Fishbein D.H., Reuland M. Psychological correlates of frequency and type of drug use among jail inmates. Addict. Behav. 19:1994;583-598.
21. Gutierres S.E., Todd M. The impact of childhood abuse on treatment outcomes of substance users. Profess. Psycho: Res. Pract. 28(Suppl. 4):1997;348-354.
22. Han K., Weed N.C., Calhoun R.F., Butcher J.N. Psychometric characteristics of the MMPI-2 Cook-Medley Hostility Scale. J. Pers. Assess. 65(Suppl. 3):1995;567-585.
23. Hubbard R.L., Marsden M.E., Rachal J.V. Drug abuse treatment: A national study of effectiveness. 1989;University of North Carolina Press, Chapel Hill, NC.
24. Joe G.W., Simpson D.D. Retention in treatment of drug users: 1971-1972 DARP admissions. Am. J. Drug Alcohol Abuse. 2:1975;63-71.
25. Karuntzos G.T., Caddell J.M., Dennis M.L. Gender differences in vocational needs and outcomes for methadone treatment clients. Theme Issue: Treatment of opioid dependence: Current issues and future prospects. J. Psychoact. Drugs. 26(Suppl. 2):1994;173-180.
26. Kosten T.R., Rounsaville B.J., Kleber H.D. DSM-III personality disorders in opiate addicts. Compr. Psychiatry. 23:1982;572-581.
27. Kranzler H.R., Del Boca F.K., Rounsaville B.J. Comorbid psychiatric diagnosis predicts three-year outcomes in alcoholics: A posttreatment natural history study. J. Stud. Alcohol. 57:1996;619-626.
28. Lawler K.A., Harralson T.L., Armstead C.A., Schmied L.A. Gender and cardiovascular responses: What is the role of hostility? J. Psychosom. Res. 37(Suppl. 6):1993;603-613.
29. Leal J., Ziedonis D., Kosten T. Antisocial personality disorder as a prognostic factor for pharmacotherapy of cocaine dependence. Drug Alcohol Depend. 35(Suppl. 1):1994;31-35.
30. Levy S.J., Doyle K.M. Attitudes toward women in a drug abuse treatment program. J. Drug Issues. 4:1974;428-434.
31. Ling W., Charuvastra V.C., Kaim S.C., Klett C.J. Methadyl acetate and methadone as maintenance treatments for heroin addicts. Arch. Gen. Psychiatry. 33:1976;709-720.
32. Marsh J.C., Miller N.A. Female clients in substance abuse treatment. Int. J. Addict. 20:1985;995-1019.
33. McCormick R., Smith M. Aggression and hostility in substance abusers: The relationship to abuse patterns coping style and relapse triggers. Addict. Behav. 20(Suppl. 5):1995;555-562.
34. McLellan A.T. Patient characteristics associated with outcome. Cooper J.R., Altman F., Brown B.S. et al. Research on the treatment of narcotic addiction: State of the Art, NIDA Treatment Research Monograph Series, No. ADM 83-1281, National Institute on Drug Abuse, Rockville, MD. 1983;500-529.
35. McLellan A.T., Luborsky L., O'Brien C.P., Woody G.E., Druley K.A. Is treatment for substance abuse effective? J. Am. Med. Assoc. 247:1982;1423-1427.
36. McLellan A.T., Luborsky L., Cacciola J., Griffith J.E. New data from the Addiction Severity Index. Reliability and validity in three centers. J. Nerv. Ment. Dis. 173:1985;412-423.
37. McLellan A.T., Luborsky L., O'Brien C.P., Barr H.L. Alcohol and drug abuse treatment in three difference populations: Is there improvement and is it predictable? Am. J. Drug Alcohol Abuse. 12(1):1986;101-120.
38. McMahon R.C., Kelley A., Kouzekanani K. Personality and coping styles in the prediction of dropout from treatment for cocaine abuse. J. Pers. Assess. 61(Suppl. 1):1993;147-155.
39. Metzger D.S., Woody G.E., McLellan A.T., O'Brien C.P., Druley P., Navaline H., DePhilipps D., Stolley P., Abrutyn E. Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: An 18-month prospective follow-up. J. Acquir. Immune Defic. Syndr. 6:1993;1049-1056.
40. Moss H.B. Psychopathy, aggression and family history in male veteran substance abuse patients: A factor analytic study. Addict. Behav. 14(Suppl. 5):1989;565-570.
41. Nurco D.N., Shaffer J.W., Ball J.C., Kinlock T.W. Trends in the commission of crime among narcotic addicts over successive periods of addiction and nonaddiction. Am. J. Drug Alcohol Abuse. 10:1984;481-489.
42. Petry N.M., Bickel W.K. Buprenorphine self-administration in buprenorphine-maintained outpatients: Effects of an alternate reinforcer, behavioral economic analysis of demand and dissociation of subjective and reinforcing effects. Exp. Clin. Psychopharm. 7(Suppl. 1):1999;1-11.
43. Petry N.M., Bickel W.K., Badger G.J. A comparison of four buprenorphine dosing regimens in the treatment of opioid dependence. Clin. Pharmacol. Ther. 66:1999;306-314.
44. Petry, N.M., Bickel, W.K., Badger, G.J., 1999b. A comparison of four buprenorphine dosing regimens using open-dosing procedures. Is twice weekly dosing possible? In review.
45. Project MATCH secondary a priori hypotheses. Addiction. 92:1997;1671-1698.
46. Ravndal E., Vaglum P. Changes in antisocial, aggressiveness during treatment in hierarchical therapeutic community. Acta Psychiatr. Scand. 84:1991;524-530.
47. Reed B.G. Developing women-sensitive drug dependence treatment services: Why so difficult? J. Psychoact. Drugs. 19:1987;151-164.
48. Renson G.J., Adams J.E., Tinklenberg J.R. Buss-Durkee assessment and validation with violent versus non-violent chronic alcohol abusers. J. Consult. Clin. Psychol. 46:1978;360-361.
49. Rosen M.I., Wallace E.A., McMahon T.J., Pearall H.R. Buprenorphine: Duration of blockade of effects of intramuscular hydromorphone. Drug Alcohol Depend. 35(Suppl. 2):1994;141-149.
50. Rounsaville B.J., Kosten T.R., Weissman M.M., Kleber H.D. Prognostic significance of psychopathology in treated opiate addicts: A 2.5-year follow-up study. Arch. Gen. Psychiatry. 43(Suppl. 8):1986;739-745.
51. Rounsaville B.J., Kosten T.R., Kleber H.D. The antecedents and benefits of achieving abstinence in opioid addicts: A 2.5-year follow-up study. Am. J. Drug Alcohol Abuse. 13(Suppl. 3):1987;213-229.
52. Saxon A.J., Calsyn D.A., Jackson T.R. Longitudinal changes in injection behaviors in a cohort of injection drug users. Addiction. 89(Suppl. 2):1994;191-202.
53. Schuckit M.A. The clinical implications of primary diagnostic groups among alcoholics. Arch. Gen. Psychiatry. 42:1985;1043-1049.
54. Simpson D.D. The relation of time spent in drug abuse treatment to posttreatment outcomes. Am. J. Psychiatry. 136:1979;1449-1453.
55. Simpson D.D. Treatment for drug abuse: Follow-up outcomes and length of time spent. Arch. Gen. Psychiatry. 39(Suppl. 8):1981;875-880.
56. Simpson D.D., Sells S.B. Effectiveness of treatment for drug abuse: An overview of the DARP research program. Adv. Alcohol Subst. Abuse. 2(Suppl. 1):1982;7-29.
57. Stark M.J. Dropping out of substance abuse treatment: A clinically oriented review. Clin. Psychol. Rev. 12:1992;93-116.
58. Stark M.J., Campbell B.K. Personality, drug use and early attrition from substance abuse treatment. Am. J. Drug Alcohol Abuse. 14(Suppl. 4):1988;475-485.
59. Strain E.C., Stitzer M.L., Liebson I.A. et al. Comparison of buprenorphine and methadone in the treatment of opioid dependence. Am. J. Psychiatry. 151:1994;1025-1030.
60. Vickers-Lahti M., Garfield F., McCusker J., Hindin R. The relationship between legal factors and attrition from a residential drug abuse treatment program. J. Psychoact. Drugs. 27(Suppl. 1):1995;17-25.
61. Woody G.E., McLellan A.T., Luborsky L., O'Brien C.P., Blaine J., Fox S., Herman I., Beck A.T. Severity of psychiatric symptoms as a predictor of benefits from psychotherapy: The Veterans Administration-Penn study. Am. J. Psychiatry. 141:1984;1172-1177.
62. Woody G.E., McLellan A.T., Luborsky L., O'Brien C.P. Psychotherapy in community methadone programs: A validation study. Am. J. Psychiatry. 152:1995;1302-1308.
63. Woodhouse L.D. An exploratory study of the use of life history methods to determine treatment needs for female substance abusers. Resp. Victim Women Child. 13:1990;12-15.